An acute and continuation phase study of the comparative efficacy of venlafaxine ER (Effexor XR) and fluoxetine (Prozac) in achieving and sustaining remission (wellness) in patients with recurrent unipolar major depression; followed by a long term randomized, placebo-controlled maintenance treatment study in patients treated initially with venlafaxine ER

Trial Profile

An acute and continuation phase study of the comparative efficacy of venlafaxine ER (Effexor XR) and fluoxetine (Prozac) in achieving and sustaining remission (wellness) in patients with recurrent unipolar major depression; followed by a long term randomized, placebo-controlled maintenance treatment study in patients treated initially with venlafaxine ER

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Sep 2015

At a glance

  • Drugs Fluoxetine; Venlafaxine
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Acronyms PREVENT
  • Most Recent Events

    • 01 Sep 2015 Results of post hoc analysis presented at the 28th Annual Congress of the European College of Neuropsychopharmacology
    • 18 Aug 2009 Actual initiation date (1 Aug 2000) added as reported by ClinicalTrials.gov.
    • 18 Aug 2009 Actual end date (1 Oct 2005) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top